About Bioneer

Bioneer is a Danish, not-for-profit, R&D-based company owned by the Technical University of Denmark and specialized in early validation of pharmaceutical candidates, formulation development- and characterization and recombinant protein production. Bioneer is an approved technological service partner (accreditation from the Danish government), and thereby committed to develop advanced technologies for the Danish- and international biotech industry.

Early validation studies are carried out through human disease models based on iPSC (stem cell reprogramming) technology, immune pathway models (DC & T-cell) and biomarker- and histological analysis. In the preclinical stage, Bioneer offer compound- and formulation characterization and development, including ADME properties (small molecules & biologics). Additionally, Bioneer possess a unique, advanced dynamic gut model, which allows the prediction of bio-performance in a physiological in-vitro model. Finally, Bioneer has vast experience with production of recombinant proteins in advanced microbial- and mammalian strains and can offer strain development and -optimization along with upstream- and downstream process development.

Bioneer is serving a large portion of Danish (and international) biotech companies in discovery- and preclinical phases. Furthermore, we collaborate internationally in the framework of EU and Eurostars.

We welcome discussions with companies, universities and hospitals on potential projects and collaboration possibilities.

Contact:

Hans Christian L. Wegge
Business Development Manager
Mobile: +45 2442 5855
E-mail: hcw@bioneer.dk
www.bioneer.dk


Leave a Reply

Your email address will not be published. Required fields are marked *

Back to Top ↑